ROCHE FINANCE LTD - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Entrada Therapeutics, Inc. (TRDA)

Filing Manager: ROCHE FINANCE LTD
Reporting Manager: Roche Finance Ltd
Security: Entrada Therapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol: TRDA
Shares outstanding: 37.2M shares
Disclosed Ownership: 2.57M shares
Ownership: 6.9%
Form type: SCHEDULE 13G/A
Date filed: 2/14/2025, 03:47 PM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Roche Finance Ltd	6.9%	2.57M	0	2.57M	/s/ Carole Nuechterlein	Carole Nuechterlein, Authorized Signatory
Roche Holding Ltd	6.9%	2.57M	0	2.57M	/s/ Peter Trybus	Peter Trybus, Authorized Signatory